TNFRSF11A and B-cell chronic lymphocytic leukemia: CD16 is a RANK co-receptor, contributing to the amplification of osteoclast differentiation [65]; this evidence, along with the previous observations, prompted us to evaluate, first, the percentage of monocyte subtypes in a cohort of PBMCs from 35 CLL patients, and second, whether the eventual expansion of a particular subset could be related to the enhanced rate of bone erosion previously reported [8].